The Bioprocess industry has an urgent need for large quantities of buffers. Coupled with supply chain disruption caused by the Coronavirus pandemic, this has put additional pressure on drug manufacturers. To secure buffer supplies in sufficient quantities, manufacturers need to have extensive warehouse space for drum storage and the capacity to receive multiple deliveries of large amounts of buffer every week.
An alternative to buffer delivery, the industry can turn to automated stainless steel dilution systems or making buffers by hand in single-use vessels. Stainless steel dilution systems can have a lead time of six months or longer, demand a large site footprint, and require validated cleaning procedures before use. These methods of buffer creation pose challenges for biopharmaceutical manufactures, and their chosen method is key to the overall success or failure of their operation.
This webinar will examine the existing challenges with buffer delivery and creation while exploring customer driven solutions. We will introduce how advances in mixing technologies can assist biopharmaceutical manufacturers to consistently produce on-demand or bulk buffer. This encompasses a new technology which gently mixes concentrate and WFI to produce buffer, without foaming, that can be observed in stainless steel equipment.
Register today to begin optimizing your buffer creation through a streamlined process allowing for on-demand production at the point of use.
Key learning objectives
- Addressing challenges surrounding buffer manufacturing post-pandemic
- Recognize limitations of existing approaches for buffer manufacturing
- Learn about a unique solution for efficient on demand buffer creation
Target audience
- Upstream Process Development
- Upstream Processing Managers
- Quality Assurance
- Operations Managers
- Manufacturing Science and Technology
- Process Engineering
- Process Sciences
- Manufacturing Services
- Manufacturing Support
